Guest Columns
-
This Industrial Fungus Has Protein Expression Promise For Pharma
2/12/2026
Trichoderma reesei is well characterized for industrial uses. A Finnish research group is exploring it for pharmaceutical protein expression.
-
Real-World Phase-Appropriate Control Lessons For mAb/ADC Manufacturers
2/4/2026
Effective mAb and ADC manufacturing control strategies evolve through the phases. These four principles should guide your strategy design as goals shift.
-
High Specific Productivity For Leaner Sustainable Bioprocessing
1/30/2026
Improving specific productivity moves the goal beyond pumping out higher titers, but it demands a deeper understanding of cellular biology and protein expression.
-
New ISPE Framework Targets Uncertainty In Pharma's AI Deployment
1/29/2026
International Society for Pharmaceutical Engineering members developed the guide to offer a risk-based framework for evaluating, implementing, and maintaining AI systems.
-
Facility Considerations When Retrofitting Legacy Sites For ADCs
1/26/2026
Antibody-drug conjugate manufacturing requires, among other things, unidirectional flow and air locks for people and materials. Facilities often lack these attributes.
-
The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
1/21/2026
The promise of AI is colliding with the harsh reality of data chaos in pharma manufacturing. This article explores why most AI investments fail, and a 5-layer solution.
-
Why Use Total Organic Carbon Analysis For Cleaning Validation?
1/21/2026
Total organic carbon analysis is probably the most “fit for use” analytical method to validate cleaning processes, particularly within a science- and risk-based approach.
-
Do's And Don'ts Of Material Handling When Retrofitting For ADCs
1/20/2026
Antibody-drug conjugate manufacturing includes extremely dangerous ingredients, and most legacy facilities lack the features and flows for safe handling.
-
Building Enterprise Resilience From QRM Signals
1/16/2026
Turn enterprise resource management (ERM) from a checklist into a true decision system — so risk informs everyday choices before quality events become supply disruptions, delays, or regulatory exposure.
-
Single-Use Standards Are Maturing, But The Process Remains King
1/13/2026
The food industry inspired single-use in biopharma, but the regulatory landscape is far more complex. If you're worried about compliance, this discussion can help.